WCG acquires CTMS internet platform for its growing network

By Maggie Lynch

- Last updated on GMT

(Image:Getty/Urupong)
(Image:Getty/Urupong)

Related tags CTMS Research research network WCG Drug development Transparency

WCG acquires Velos’ CTMS internet platform to provide drug development and research management to its large institutional research network.

WIRB-Copernicus Group (WCG) clinical service division’s acquisition of Velos eResearch will give WCG’s network access to clinical research simplification capabilities through clinical trial management software.

Velos eResearch manages institutional research by housing study status, patient enrollment, calendars, budgets, billing, and electronic data capture in one place. The company states the platform increases efficiency, transparency and accessibility of institutional research.

According to WCG, it partners with 93% of institutions and 90% of the academic medical centers that conduct research in the US. Donald Deieso, executive chairman and CEO of WCG, stated that the group serves more than 2,800 institutions.  

Through this partnership with the institutions, WCG states it facilitates drug development, providing solutions to increase efficiency and profitability of their research, as well as accelerating patient enrollment.

John McIlwain, co-founder and CEO of Velos, said that its clients are a “critical part of the clinical research ecosystem. It is our mission to break down the silos and administrative barriers slowing their progress and limiting their growth, to enable them to accelerate breakthroughs in clinical care.”

Velos will operate independently and retain its headquarters in Fremont, California. WCG will support Velos with access to capital, expertise and corporate operational support.

WCG has acquired and collaborated with multiple companies to expand its pharmacovigilance​, trial benchmarking​, and data monitoring​ services. 

Related news

Show more

Related products

show more

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 16-Jan-2023 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Optimizing Adherence in DCTs

Optimizing Adherence in DCTs

PPD - Decentralized Clinical Trials | 12-Jan-2023 | Technical / White Paper

Prioritizing greater patient-centricity and creating an opportunity to reach unprecedented patient groups, decentralized and hybrid clinical trials are...

PPD is Supporting Complex EU DCTs

PPD is Supporting Complex EU DCTs

PPD - Decentralized Clinical Trials | 05-Jan-2023 | Technical / White Paper

PPD supports European DCTs and clinical trial sponsors with a holistic and comprehensive approach

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 14-Dec-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us

Products

View more

Webinars